MoonLake Immunotherapeutics Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q1 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
MoonLake Immunotherapeutics quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q1 2022.
  • MoonLake Immunotherapeutics Common Stock, Shares, Outstanding for the quarter ending April 5, 2022 was 52.7M shares.
Common Stock, Shares, Outstanding, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 52.7M Apr 5, 2022 10-K 2024-02-29
Q3 2021 2.88M Sep 30, 2021 10-Q/A 2021-12-14
Q4 2020 430K Dec 31, 2020 10-Q/A 2021-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.